Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The contract provides partial funding for ongoing development of ARX-04, including Phase 3 clinical, manufacturing and regulatory activities.
read more
The FDA has published a warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require ...
read more
Supporting a company’s investigational products is one of the most important functions of a medical science liaison (MSL). According to a recent survey by primary intelligence firm Cutting Edge Information, MSLs typically perform about 16 activities...
read more
Preferred Experience Varies among Pharmaceutical Companies
read more
Pharma event launches a range of packages for industry partners to implement charity giving.
read more
Completing a major expansion of its biologics and vaccines production facility in Germany late last year, IDT Biologika established highly automated filling and freeze-drying operations, establishing the basis for large scale commercial manufacturing...
read more
The Russian pharmaceutical market is developing rapidly; it takes 11th place in the rating of pharmaceutical market volumes worldwide and is predicted to go up to 9th place by 2016. Along with its growing potential, important changes in the industry ...
read more
Wednesday, March 11, 2015
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced that it will hold its first virtual conference for 2015, "Headache-Free Pharma QC," on April 1 and 2, 2015.
read more
Wednesday, March 04, 2015
CRF Health today announced a complete TrialMax eCOA solution for diabetes clinical trials. Developed with clinicians and patients to optimize usability and compliance, the solution enables investigators to collect patient reported outcome assessments...
read more
The Pharma & Biopharma Outsourcing Association (PBOA) praises Representatives Leonard Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, or FDA SOS Act (H.R. 1078). The Act would exempt privately-paid user fees ...
read more
Friday, February 27, 2015
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today announced several expanded capabilities within its European Clinical ...
read more
Friday, February 27, 2015
Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach $79.8 billion by 2020, driven by new product launches and the healthcare burden of the country’s aging ...
read more
Friday, February 27, 2015
Brazil, a signature country of South America just surpassed 200 million residents. It is the main economy in Latin America and one of the most important at world level, regionally considered industrialized in spite of the variety of income, from very...
read more
Wednesday, February 25, 2015
By joining the InCrowd information exchange, Skipta members benefit from personalized access to contribute insights and conveniently complete short, focused research surveys.
read more
Wednesday, February 25, 2015
The lack of biosimilars in the growth hormone deficiency (GHD) treatment pipeline does not signify a missed opportunity, because superior products exist in the form of next-generation biologics known as biobetters, says an analyst with research and ...
read more